Nonoperating Income (Expense) in USD of Vicapsys Life Sciences, Inc. from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Vicapsys Life Sciences, Inc. quarterly/annual Nonoperating Income (Expense) history and change rate from Q1 2021 to Q3 2024.
  • Vicapsys Life Sciences, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$36.6K, a 43.6% increase year-over-year.
  • Vicapsys Life Sciences, Inc. annual Nonoperating Income (Expense) for 2023 was -$135K.
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)

Vicapsys Life Sciences, Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$36.6K +$28.3K +43.6% Jul 1, 2024 Sep 30, 2024 10-Q 2025-01-10
Q2 2024 -$8.25K Apr 1, 2024 Jun 30, 2024 10-Q 2025-01-10
Q1 2024 $123K Jan 1, 2024 Mar 31, 2024 10-Q 2025-01-10
Q3 2023 -$64.9K Jul 1, 2023 Sep 30, 2023 10-Q 2025-01-10
Q1 2021 $100K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13

Vicapsys Life Sciences, Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$135K Jan 1, 2023 Dec 31, 2023 10-K 2024-10-21
2021 $100K Jan 1, 2021 Dec 31, 2021 10-K 2023-04-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.